<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Q32 Bio Announces Merger Closing with Homology Medicines & Private Placement of $42 Million

CU experts offer tips and resources for researchers who aspire to create their own technologies to help patients.

by PR Newswire | March 25, 2024
Q32 Bio Logo Image

Becoming a successful innovator and entrepreneur can be a daunting and difficult process, which is why the University of Colorado Anschutz Medical Campus has developed extensive resources to help its researchers find success in developing novel ways to help others. With hopes of inspiring faculty and offering tangible advice, the CU Department of Medicine highlighted these resources during its latest Research Achievement Highlights (REACH) forum through presentations by two experts: V. Michael Holers, MD, and Gali Baler, PhD.    

Topics: Press Coverage